You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism

Article metrics

Article menu
Basic tumor immunology
Original research
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism

 

Online download statistics by month:

Online download statistics by month: November 2021 to December 2025

AbstractFullPdf
Nov 202126042606834
Dec 2021551560200
Jan 2022394410197
Feb 2022285318191
Mar 2022329351153
Apr 2022313322154
May 2022429445173
Jun 2022374383134
Jul 2022307312121
Aug 2022221225110
Sep 2022214215101
Oct 202219019593
Nov 202227127183
Dec 202215115155
Jan 202312112367
Feb 202316416463
Mar 202318318896
Apr 202313913954
May 202315415476
Jun 202312612741
Jul 202320920969
Aug 202327727780
Sep 202313813868
Oct 202327827991
Nov 202351651769
Dec 202329329469
Jan 202411511644
Feb 202410310345
Mar 2024162164152
Apr 202421021369
May 202413213256
Jun 202411211248
Jul 202417117367
Aug 202433433747
Sep 202422022150
Oct 202429229381
Nov 202425225380
Dec 202416917374
Jan 202516817067
Feb 202525025043
Mar 202524825059
Apr 202520920994
May 202522623491
Jun 202514414467
Jul 2025110
Dec 2025100
Total12750129214676